Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5126]

Phase III study finds initial nivolumab-based treatment halts melanoma...

Dr Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA

Phase III study finds initial nivolumab-based treatment halts melanoma progression ( Dr Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA )

New targeted treatments for blood cancers: Multiple myeloma, non-Hodgkin...

Dr Merry-Jennifer Markham - University of Florida, Florida, USA

New targeted treatments for blood cancers: Multiple myeloma, non-Hodgkin lymphoma, genomic marker mismatch repair and myelofibrosis ( Dr Merry-Jennifer Markham - University of Florida, Florida, USA )

Targeted drug daratumumab shows promise in heavily treatment-resistant multiple...

Dr Saad Zafar Usmani - Levine Cancer Institute, Charlotte, USA

Targeted drug daratumumab shows promise in heavily treatment-resistant multiple myeloma ( Dr Saad Zafar Usmani - Levine Cancer Institute, Charlotte, USA )

Ibrutinib combination regimen shows substantial benefits in relapsed CLL

Dr Asher Chanan-Khan - Mayo Clinic, Jacksonville, USA

Ibrutinib combination regimen shows substantial benefits in relapsed CLL ( Dr Asher Chanan-Khan - Mayo Clinic, Jacksonville, USA )

Novel targeted drug palbociclib slows progression of hormone receptor-positive...

Dr Nicholas Turner - The Institute of Cancer Research, London, UK

Novel targeted drug palbociclib slows progression of hormone receptor-positive breast cancer ( Dr Nicholas Turner - The Institute of Cancer Research, London, UK )

Anastrozole offers higher breast cancer-free survival rates than tamoxifen...

Prof Richard Margolese - The Jewish General Hospital, McGill University...

Anastrozole offers higher breast cancer-free survival rates than tamoxifen following DCIS ( Prof Richard Margolese - The Jewish General Hospital, McGill University, Montreal, Canada )

Extensive lymph node surgery may not be necessary for some patients with...

Prof Claus Garbe - University of Tübingen, Tübingen, Germany

Extensive lymph node surgery may not be necessary for some patients with melanoma ( Prof Claus Garbe - University of Tübingen, Tübingen, Germany )

Effective adjuvant chemotherapy for high-risk, localised prostate cancer

Prof Howard Sandler - Cedars Sinai Medical Center, Los Angeles, USA

Effective adjuvant chemotherapy for high-risk, localised prostate cancer ( Prof Howard Sandler - Cedars Sinai Medical Center, Los Angeles, USA )

Novel JAK inhibitor pacritinib proving effective for easing symptoms of...

Dr Ruben Mesa - Mayo Clinic Cancer Center, Scottsdale, USA

Novel JAK inhibitor pacritinib proving effective for easing symptoms of myelofibrosis ( Dr Ruben Mesa - Mayo Clinic Cancer Center, Scottsdale, USA )

Novel targeted drug palbociclib slows progression of hormone receptor-positive...

Dr Nicholas Turner - The Institute of Cancer Research, London, UK

Novel targeted drug palbociclib slows progression of hormone receptor-positive breast cancer ( Dr Nicholas Turner - The Institute of Cancer Research, London, UK )

Anastrazole offers higher breast cancer-free survival rates than tamoxifen...

Prof Richard Margolese - The Jewish General Hospital, McGill University...

Anastrazole offers higher breast cancer-free survival rates than tamoxifen following DCIS ( Prof Richard Margolese - The Jewish General Hospital, McGill University, Montreal, Canada )

Eribulin extends overall survival for patients with advanced liposarcoma and...

Dr Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium

Eribulin extends overall survival for patients with advanced liposarcoma and leiomyosarcoma ( Dr Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium )

More from ecancer